Safi Shahda

HCRN-GI14-186

A Multi-Center, Single Arm, Phase II study of Pembrolizumab (MK-3475) in Combination with Chemotherapy for Patients with Advanced Colorectal Cancer: HCRN GI14-186
Status
Closed
Cancer Types
Colorectal
Locations